Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23111
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMakis, A. C.en
dc.contributor.authorHatzimichael, E. C.en
dc.contributor.authorKolios, G.en
dc.contributor.authorBourantas, K. L.en
dc.date.accessioned2015-11-24T19:30:31Z-
dc.date.available2015-11-24T19:30:31Z-
dc.identifier.issn1592-8721-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23111-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAnemia, Sickle Cell/*blood/*drug therapyen
dc.subjectAntisickling Agents/*therapeutic useen
dc.subjectEndothelin-3/*blooden
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHydroxyurea/*therapeutic useen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.titleCirculating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatmenten
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15020278-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2004-
heal.abstractAbnormal adhesion of red blood cells to the endothelium and the production of cytokines and vasoactive substances, such as endothelin-1 contribute to the pathogenesis of microvascular occlusion in sickle cell disease (SCD), even during the steady state. Endothelin-3 (ET-3) is a vasoconstrictive agent, which has not yet been studied in SCD.en
heal.journalNameHaematologicaen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Bourantas-2004-circulating endothelin 3.pdf228.34 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons